Open Access Articles- Top Results for Meglumine antimoniate

Meglumine antimoniate

Meglumine antimoniate
File:Meglumine antimoniate major component 3D.png
Systematic (IUPAC) name
Hydroxy-dioxostiborane; (2R,3R,4R,5S)-6-methylaminohexane-1,2,3,4,5-pentol
Clinical data
AHFS/ Micromedex Detailed Consumer Information
133-51-7 7pxN
P01CB01 QP51AB01
PubChem CID 64953
ChemSpider 58479 7pxY
ChEMBL CHEMBL239129 7pxY
NIAID ChemDB 008733
Chemical data
Formula Variable
 14pxN (what is this?)  (verify)

Meglumine antimoniate (or meglumine antimonate) is a medicine used for treating leishmaniasis.[1] It is manufactured by Aventis[2] and sold as Glucantime in France, and Glucantim in Italy. It belongs to a group of compounds known as the pentavalent antimonials. It is administered by intramuscular injection.

See also


  1. Soto, J.; Fuya, P.; Herrera, R.; Berman, J. (1998). "Topical paromomycin/methylbenzethonium chloride plus parenteral meglumine antimonate as treatment for American cutaneous leishmaniasis: Controlled study". Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 26 (1): 56–58. PMID 9455509. doi:10.1086/516267.  edit
  2. Aventis press release, 15 April 2005. Invalid language code.

Lua error in package.lua at line 80: module 'Module:Buffer' not found.